Asieris Announces Positive Phase III Bridging Trial of Hexvix®, a Diagnostic Drug for Bladder Cancer ...Middle East

SHANGHAI, Aug. 11, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that the Phase III bridging...

Hence then, the article about asieris announces positive phase iii bridging trial of hexvix a diagnostic drug for bladder cancer was published today ( Friday 11/08/2023 - 12:01 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Asieris Announces Positive Phase III Bridging Trial of Hexvix®, a Diagnostic Drug for Bladder Cancer )

Also on site :

• Trump vs Massie in Kentucky: Is Israel breaking MAGA?
• Bolt CEO says he let go of his entire HR team for creating problems that didn’t exist: ‘Those problems disappeared when I let them go’: 
• This New Iron Maiden x Timex Watch Features a Light-Up Cyborg Eddie. Here’s Where to Preorder It Early